Saturday, November 26, 2022

Tag: potent drug component

Dishman Carbogen Amcis Limited

Dishman Carbogen Amcis announces its major investments of around CHF 15...

0
Dishman’s subsidiary, Carbogen Amcis AG, pharmaceutical process development and Active Pharmaceutical Ingredient (API) and drug products manufacturing company, announced today a joint funding agreement...

This function has been disabled for HealthTekPak.

error: Content is protected !!